TENET HEALTHCARE CORP Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31)
TENET HEALTHCARE CORP (THC) reported Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) of $109.00 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-04.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss · last filed 2020-05-04
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2020-03-31 was $109.00M, a 27.33% decline year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-12-31 was $318.00M, a 41.33% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $156.00M, a 23.81% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $141.00M, a 6.82% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2019 was $765.00M, a 27.71% increase from fiscal 2018.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2018 was $599.00M, a 7.35% increase from fiscal 2017.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2017 was $558.00M, a 2.62% decline from fiscal 2016.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2016 was $573.00M, a 31.42% increase from fiscal 2015.
| Period end | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $109.00M 10-Q · filed 2020-05-04 | $427.00M derived: sum of 2 quarters · filed 2020-05-04 | $583.00M derived: sum of 3 quarters · filed 2020-05-04 | $724.00M derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-12-31 | $318.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $474.00M derived: sum of 2 quarters · filed 2020-02-24 | $615.00M derived: sum of 3 quarters · filed 2020-02-24 | $765.00M 10-K · filed 2020-02-24 |
| 2019-09-30 | $156.00M 10-Q · filed 2019-11-04 | $297.00M derived: sum of 2 quarters · filed 2019-11-04 | $447.00M 10-Q · filed 2019-11-04 | $672.00M derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-06-30 | $141.00M 10-Q · filed 2019-08-05 | $291.00M 10-Q · filed 2019-08-05 | $516.00M derived: sum of 3 quarters · filed 2020-05-04 | $642.00M derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-03-31 | $150.00M 10-Q · filed 2020-05-04 | $375.00M derived: sum of 2 quarters · filed 2020-05-04 | $501.00M derived: sum of 3 quarters · filed 2020-05-04 | $633.00M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $225.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $351.00M derived: sum of 2 quarters · filed 2020-02-24 | $483.00M derived: sum of 3 quarters · filed 2020-02-24 | $599.00M 10-K · filed 2020-02-24 |
| 2018-09-30 | $126.00M 10-Q · filed 2019-11-04 | $258.00M derived: sum of 2 quarters · filed 2019-11-04 | $374.00M 10-Q · filed 2019-11-04 | $556.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $132.00M 10-Q · filed 2019-08-05 | $248.00M 10-Q · filed 2019-08-05 | $430.00M derived: sum of 3 quarters · filed 2020-02-24 | $573.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $116.00M 10-Q · filed 2019-04-29 | $298.00M derived: sum of 2 quarters · filed 2020-02-24 | $441.00M derived: sum of 3 quarters · filed 2020-02-24 | $559.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $325.00M derived: sum of 2 quarters · filed 2020-02-24 | $443.00M derived: sum of 3 quarters · filed 2020-02-24 | $558.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | $143.00M 10-Q · filed 2018-11-05 | $261.00M derived: sum of 2 quarters · filed 2018-11-05 | $376.00M 10-Q · filed 2018-11-05 | $585.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $118.00M 10-Q · filed 2018-08-06 | $233.00M 10-Q · filed 2018-08-06 | $442.00M derived: sum of 3 quarters · filed 2019-02-25 | $571.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $115.00M 10-Q · filed 2018-04-30 | $324.00M derived: sum of 2 quarters · filed 2019-02-25 | $453.00M derived: sum of 3 quarters · filed 2019-02-25 | $583.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $209.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $338.00M derived: sum of 2 quarters · filed 2019-02-25 | $468.00M derived: sum of 3 quarters · filed 2019-02-25 | $573.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $129.00M 10-Q · filed 2017-11-07 | $259.00M derived: sum of 2 quarters · filed 2017-11-07 | $364.00M 10-Q · filed 2017-11-07 | $739.00M derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | $130.00M 10-Q · filed 2017-08-07 | $235.00M 10-Q · filed 2017-08-07 | $610.00M derived: sum of 3 quarters · filed 2017-08-07 | $662.00M derived: sum of 4 quarters · filed 2017-08-07 |
| 2016-03-31 | $105.00M 10-Q · filed 2017-05-01 | $480.00M derived: sum of 2 quarters · filed 2017-05-01 | $532.00M derived: sum of 3 quarters · filed 2017-05-01 | |
| 2015-12-31 | $375.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $427.00M derived: sum of 2 quarters · filed 2017-02-27 | $436.00M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $52.00M 10-Q · filed 2015-11-02 | $61.00M 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |